Epigenetic Screening Trends in Drug Discovery

There’s an interesting piece on epigenetics screening in the Spring 2011 Drug Discovery World called, “EPIGENETICS an emerging target class for drug screening”. The author, Dr. John Comley, is from HTStec, a market research consultancy.

In the article Dr. Comley shares results from HTStec’s June 2010 Screening Trends Report and also profiles vendors’ latest developments which includes RapidFire label-free technology and fee-for-service epigenetic screening offerings.

You can read customer case studies and watch our epigenetics talk to learn more about RapidFire Epigenetics Screening Programs.

Advertisement